X-ray crystal structural analysis of [NMe4][Re(CO)3(CMSAH)] was performed to interpret the nature of 99mTc tracers. CMSAH3 and TDSAH4 were radiolabeled by incubating each ligand and the precursor [99mTc(CO)3(H2O)3]+ at 70°C (pH 7) for 30 min. The products were purified by reversed-phase high-performance liquid chromatography, and biodistribution studies were performed in Sprague–Dawley rats, with 131I-OIH as an internal control at 10 and 60 min.
Radiolabeling CMSAH3 and TDSAH4 with the [99mTc(CO)3(H2O)3]+ precursor gave products quantitatively. Analysis of the Re(CO)3 complexes with the CMSAH3 and TDSAH4 ligands demonstrates that ligands are bound in 99mTc/Re(CO)3 complexes through a thioether and two deprotonated carboxyl groups (forming tridentate dianionic moieties, generally with two 5-membered chelate rings). Renal excretion at 60 min (activity in the urine as a percentage of 131I-OIH) was 68±1%for Na3[99mTc(CO)3(TDSA)] but was 98±1%for Na2[99mTc(CO)3(CMSA)].
In rats, Na2[99mTc(CO)3(CMSA)] is extracted by the kidneys and eliminated in the urine almost as rapidly as 131I-OIH; consequently, Na2[99mTc(CO)3(CMSA)] may provide a direct measure of effective renal plasma flow, and further evaluation in humans is warranted.